Hepatocellular carcinoma (HCC)—closely associated with liver cirrhosis and, in fact, the
main cause of death in patients with such disease—is now recognized as one of the most …

Intermediate-stage Hepatocellular Carcinoma (HCC) represents a wide range of disease
burden. Patients with different levels of liver function, tumor size, and number of lesions may …

It is unclear whether hepatic artery infusion chemotherapy (HAIC) or transcatheter arterial
chemoembolization (TACE) is more efficient in the combination therapy of hepatocellular …

Simple Summary Systemic chemotherapies have revolutionized therapeutic paradigms for
hepatocellular carcinoma (HCC) over the past decade. Various regimens have …

Advanced hepatocellular carcinoma (HCC) is traditionally associated with limited treatment
options and a poor prognosis. Sorafenib, a multiple tyrosine kinase inhibitor, was introduced …

© HepatoBiliary Surgery and Nutrition. All rights reserved. HepatoBiliary Surg Nutr 2018; 7
(1): 41-43 hbsn. amegroups. com the Chinese guidelines are distinguished by an extensive …

BACKGROUND Significant controversy exists as to which treatment modality is most
effective for small, solitary hepatocellular carcinomas (HCCs): radiofrequency ablation …

Objectives To compare the efficacy of transarterial chemoembolization (TACE) and
radiofrequency ablation (RFA) for patients with single small (≤ 3 cm) hepatocellular …

4093 Background: The initial report of the multicenter SURF trial (surgery vs. radiofrequency
ablation [RFA] for small hepatocellular carcinoma [HCC]) showed that recurrence-free …

Background: Various therapeutic strategies are available for the first-line treatment of
patients with advanced hepatocellular carcinoma (aHCC). But which approach is the most …